FibroBiologics, Inc. (FBLG)

1.36 -0.07 (-4.90%) USD  |  NASDAQ  |  Sep 21, 16:00
1.48 +0.12 (+8.82%) After-Hours: 04:50
More

FibroBiologics EPS Diluted (Quarterly) : -0.6564 for June 30, 2026

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for FBLG.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2022. Start Trial.
Date Value
June 30, 2026 -0.6564
March 31, 2026 -1.325
December 31, 2025 -0.9754
September 30, 2025 -2.683
June 30, 2025 -2.411
March 31, 2025 -0.1354
December 31, 2024 -1.822
September 30, 2024 -0.0149
Date Value
June 30, 2024 0.0274
March 31, 2024 -0.2586
December 31, 2023 -0.3442
September 30, 2023 -0.0675
June 30, 2023 -1.330
March 31, 2023 -0.1524
December 31, 2022 -0.938
September 30, 2022 -0.0481

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 0.1822
Alnylam Pharmaceuticals, Inc. 1.207
Anika Therapeutics, Inc. 0.2412
Savara, Inc. -0.1587
Vericel Corp. 0.0422

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -4.117M
Total Expenses (Quarterly) 4.117M
Enterprise Value 6.217M
Earnings Yield -414.7%
Normalized Earnings Yield -388.56